** Shares of Cochlear COH.AX fall as much as 1.3% to A$309.090
** Shares of the healthcare technology co set for their weakest week since December 9, 2024, if losses hold
** The priciest stock in ASX is tracking losses seen by the country's healthcare sub-index .AXHJ, which is down 0.7%
** UBS hikes stock's price target to A$270 from A$265, retains "sell" rating
** Brokerage made changes to their foreign exchange estimates, underlying assumptions are unchanged
** Three of 15 analysts rate the stock "buy" or higher, 10 "hold" and two "sell"; their median PT is A$305.00 – LSEG data
** Stock fell 8.8% in 2024
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com;))